Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-11 Sale |
2024-09-12 6:00 pm |
PMV Pharmaceuticals Inc. | PMVP | Jalota Deepika Chief Development Officer |
7,218 | $1.5036 | $10,853 | 118,283 (Direct) |
View |
| 2023-09-15 Sale |
2023-09-18 4:26 pm |
PMV Pharmaceuticals Inc. | PMVP | Jalota Deepika Chief Development Officer |
4,104 | $6.62 | $27,168 | 29,946 (Direct) |
View |
| 2021-08-17 Sale |
2021-08-18 5:02 pm |
PMV Pharmaceuticals Inc. | PMVP | Jalota Deepika SVP, Regulatory Affairs and QA |
2,896 | $33.78 | $97,814 | 87,320 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-03 Option Award |
2025-03-05 6:32 pm |
N/A 2035-03-03 |
PMV Pharmaceuticals Inc. | PMVP | Jalota Deepika Chief Development Officer |
300,000 | $0 | 423,024 (Direct) |
View |
| 2024-08-13 Option Award |
2024-10-03 4:50 pm |
N/A 2034-08-13 |
PMV Pharmaceuticals Inc. | PMVP | Jalota Deepika Chief Development Officer |
215,774 | $0 | 215,774 (Direct) |
View |
| 2024-01-18 Option Award |
2024-01-22 4:06 pm |
N/A 2034-01-18 |
PMV Pharmaceuticals Inc. | PMVP | Jalota Deepika Chief Development Officer |
320,650 | $0 | 350,596 (Direct) |
View |
| 2023-05-12 Option Award |
2023-05-15 6:18 pm |
N/A 2033-05-12 |
PMV Pharmaceuticals Inc. | PMVP | Jalota Deepika Chief Development Officer |
125,000 | $0 | 125,000 (Direct) |
View |
| 2022-09-09 Option Award |
2022-09-13 4:26 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | Jalota Deepika SVP, Regulatory Affairs and QA |
34,050 | $0 | 34,050 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-28 4:28 pm |
N/A 2032-02-10 |
PMV Pharmaceuticals Inc. | PMVP | Jalota Deepika SVP, Regulatory Affairs and QA |
68,100 | $0 | 68,100 (Direct) |
View |
| 2021-08-17 Exercise |
2021-08-18 5:02 pm |
N/A 2029-08-20 |
PMV Pharmaceuticals Inc. | PMVP | Jalota Deepika SVP, Regulatory Affairs and QA |
2,896 | $0 | 87,320 (Direct) |
View |
| 2021-08-17 Exercise |
2021-08-18 5:02 pm |
N/A N/A |
PMV Pharmaceuticals Inc. | PMVP | Jalota Deepika SVP, Regulatory Affairs and QA |
2,896 | $3.53 | 87,320 (Direct) |
View |
| 2021-05-12 Option Award |
2021-06-08 7:24 pm |
N/A 2031-05-11 |
PMV Pharmaceuticals Inc. | PMVP | Jalota Deepika SVP, Regulatory Affairs and QA |
22,674 | $0 | 22,674 (Direct) |
View |
Ownership |
2020-09-24 7:11 pm |
N/A 2029-08-20 |
PMV Pharmaceuticals Inc. | PMVP | Jalota Deepika SVP, Regulatory Affairs and QA |
0 | $0 | 107,309 (Direct) |
View |